Apeptico press release

SOLNATIDE has been approved for the treatment of COVID-19 patients suffering from pulmonary oedema and acute respiratory distress syndrome by the Italian Medicines Agency and the Ethics Committee of the National Institute for Infectious Diseases (Lazzaro Spallanzani-Rome).

Click on the button below to read the PDF :


OPIS Logo OPIS Via Matteotti, 10 Desio Italy 20832 + 39 0362 6331